Abstract
Vulvovaginal candidiasis currently represents a major public health challenge due to its high incidence and reports of recurrences. These challenges are due to host-related factors, such as a compromised immune system, or pathogen-related factors, including resistance to antifungal agents, making it necessary to study new treatment alternatives, for example, substances of natural origin, …